HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Genetics and Epigenetics in Neurodegenerative Disorders
Genetics and Epigenetics in Neurodegenerative Disorders
Genetics:
Genetics is a subdivision of biology included with the study of genes, genetic variation, and heredity in organisms. Usual disorders, like Parkinson disease & Alzheimer disease, and heterogeneous heritable conditions, include ataxias and spastic paraplegias.
Epigenetics:
Epigenetics is an ongoing field in the light of potential impact on development of neurodegenerative diseases. It is a mechanism independent of DNA sequence with effects on gene transcription, yet in specific way it is heritable.
Committee Members
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States INBC 2026 Speakers
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Ananya Rajasekaran, ThinkNeuro, United States